bpj-sce-august-2020

More documents

Recommendations

Info

visit us at www.bpac.org.nz Call us on 03 477 5418 Email us at contact@bpac.org.nz Freefax us on 0800 27 22 69
Page 1 and 2:
www.bpac.org.nz SCE Issue 1 August
Page 3 and 4:
CONTENTS SCE Issue 1 August 2020 4
Page 5 and 6: Welcome to your Special Commemorati
Page 7 and 8: oxycodone has increasingly been use
Page 9 and 10: Summary: The price of safety is ete
Page 11 and 12: Early onset results in worse health
Page 13 and 14: A glucagon-like peptide 1 (GLP-1) r
Page 15 and 16: Table 1: Effects of diabetes medici
Page 17 and 18: DERMATOLOGY ANTIBIOTIC RESISTANCE &
Page 19 and 20: Erythromycin can be used for patien
Page 21 and 22: The line between normotension and h
Page 23 and 24: suitability of antihypertensive use
Page 25 and 26: CHILD HEALTH MEDICINE INDICATIONS N
Page 27 and 28: Managing insomnia without medicines
Page 29 and 30: MUSCULOSKELETAL RHEUMATOLOGY Managi
Page 31 and 32: Corticosteroid (triamcinolone aceto
Page 33 and 34: Febuxostat and CVD risk. In 2019, t
Page 35 and 36: Questions about the patient’s lif
Page 37 and 38: However, if a patient who is acutel
Page 39 and 40: MEDICINES MANAGEMENT OLDER PERSON
Page 41 and 42: emphasise that withdrawing a preven
Page 43 and 44: Stepping down PPI treatment There a
Page 45 and 46: to a poor outcome can provide insig
Page 47 and 48: is worthwhile requesting a diagnost
Page 49 and 50: GENITOURINARY SYSTEM GYNAECOLOGY AN
Page 51 and 52: Haematuria on dipstick Non-visible
Page 53 and 54: Proteinuria on dipstick Positive ur
Page 55: pacnz PRIMARY CARE UPDATE SERIES Ou
show all

bpj-sce-august-2020

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?